Discovery of potent and selective orally active inhibitors of anaplastic lymphoma kinase (ALK)

被引：0

作者：

Shakespeare, William ^{[1
]}

Fantin, Valeria ^{[1
]}

Wang, Frank ^{[1
]}

Kohlmann, Anna ^{[1
]}

Liu, Shuangying ^{[1
]}

Huang, Wei-Sheng ^{[1
]}

Wang, Yihan ^{[1
]}

Zou, Dong ^{[1
]}

Thomas, Mathew ^{[1
]}

Li, Feng ^{[1
]}

Qi, Jiwei ^{[1
]}

Cai, Lisi ^{[1
]}

Dwight, Thimothy ^{[1
]}

Xu, Yongjin ^{[1
]}

Xu, Rongsong ^{[1
]}

Dodd, Rory ^{[1
]}

Xu, Qihong ^{[1
]}

Anjum, Rana ^{[1
]}

Zhang, Sen ^{[1
]}

Keats, Jeffrey ^{[1
]}

Xue, Ling ^{[1
]}

Wardwell, Scott ^{[1
]}

Ning, Yaoyu ^{[1
]}

Moran, Lauren ^{[1
]}

Mohemmad, Qurish ^{[1
]}

Zhu, Xiaotian ^{[1
]}

Narasimhan, Narayana ^{[1
]}

Rivera, Victor ^{[1
]}

Dalgarno, David ^{[1
]}

Clackson, Tim ^{[1
]}

机构：

[1] ARIAD Pharmaceut, Cambridge, MA USA

来源：

CANCER RESEARCH | 2009年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3738

引用

页数：2

共 50 条

[21] Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers
Kinoshita, Kazutomo
Oikawa, Nobuhiro
Tsukuda, Takuo
[J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 281 - 293
[22] Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib
Huang, Qinhua
Johnson, Ted W.
Bailey, Simon
Brooun, Alexei
Bunker, Kevin D.
Burke, Benjamin J.
Collins, Michael R.
Cook, Andrew S.
Cui, J. Jean
Dack, Kevin N.
Deal, Judith G.
Deng, Ya-Li
Dinh, Dac
Engstrom, Lars D.
He, Mingying
Hoffman, Jacqui
Hoffman, Robert L.
Johnson, Patrick S.
Kania, Robert S.
Lam, Hieu
Lam, Justine L.
Le, Phuong T.
Li, Qiuhua
Lingardo, Laura
Liu, Wei
Lu, Melissa West
McTigue, Michele
Palmer, Cynthia L.
Richardson, Paul F.
Sach, Neal W.
Shen, Hong
Smeal, Tod
Smith, Graham L.
Stewart, Albert E.
Timofeevski, Sergei
Tsaparikos, Konstantinos
Wang, Hui
Zhu, Huichun
Zhu, Jinjiang
Zou, Helen Y.
Edwards, Martin P.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (04) : 1170 - 1187
[23] Cell Culture Modeling of Genotype-Directed Sensitivity to Selective Kinase Inhibitors: Targeting the Anaplastic Lymphoma Kinase (ALK)
Settleman, Jeff
[J]. SEMINARS IN ONCOLOGY, 2009, 36 (02) : S36 - S41
[24] Discovery of 3,6-diaryl-1H-pyrazolo[3,4-b]pyridines as potent anaplastic lymphoma kinase (ALK) inhibitors
Chen, Changwei
Pa, Peichen
Deng, Ziyang
Wang, Dahai
Wu, Qifan
Xu, Lei
Hou, Tingjun
Cui, Sunliang
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (07) : 912 - 916
[25] Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
Liu, Jingru
Ma, Shutao
[J]. CURRENT MEDICINAL CHEMISTRY, 2017, 24 (06) : 590 - 613
[26] Discovery of LDK378, a potent and selective anaplastic lymphoma kinase (ALK) inhibitor for the treatment of ALK-driven cancers currently in Phase 1 and 2 clinical trials
Marsilje, Thomas H.
Pei, Wei
Chen, Bei
Lu, Wenshuo
Uno, Tetsuo
Jin, Yunho
Jiang, Tao
Kim, Sungjoon
Li, Nanxin
Sarkisova, Yelena
Sun, Fanxiang
Steffy, Auzon
Pferdekamper, Anne Marie C.
Kasibhatla, Shailaja
Joseph, Sean B.
Kim, Young
Tuntland, Tove
Cui, Xiaoming
Li, Jie
Gordon, William
Richmond, Wendy
Chang, Jonathan
Groessl, Todd
He, You-Qun
Liu, Bo
Phimister, Andrew
Bursulaya, Badry
Lee, Christian
Harris, Jennifer
Michellys, Pierre-Yves
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[27] Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors
Giroux, Andre
Boulet, Louise
Brideau, Christine
Chau, Anh
Claveau, David
Cote, Bernard
Ethier, Diane
Frenette, Richard
Gagnon, Marc
Guay, Jocelyne
Guiral, Sebastien
Mancini, Joseph
Martins, Evelyn
Masse, Frederic
Methot, Nathalie
Riendeau, Denis
Rubin, Joel
Xu, Daigen
Yu, Hongping
Ducharme, Yves
Friesen, Richard W.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5837 - 5841
[28] Discovery of potent and orally active farnesyltransferase (FT) inhibitors.
Tong, YS
Wang, L
Hasvold, L
Leonard, N
Li, TM
Li, Q
Wang, WB
Cohen, J
Gu, WZ
Zhang, HY
Bauch, J
Marsh, K
Rosenberg, SH
Lin, NH
Sham, HL
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U29 - U29
[29] Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors
Pinard, Emmanuel
Alberati, Daniela
Bender, Markus
Borroni, Edilio
Brom, Virginie
Burner, Serge
Fischer, Holger
Hainzl, Dominik
Halm, Remy
Hauser, Nicole
Jolidon, Synese
Lengyel, Judith
Marty, Hans-Peter
Meyer, Thierry
Moreau, Jean-Luc
Mory, Roland
Narquizian, Robert
Norcross, Roger D.
Schmid, Philipp
Wermuth, Roger
Zimmerli, Daniel
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6960 - 6965
[30] The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia
Ho, Ginny D.
Yang, Shu-Wei
Smotryski, Jennifer
Bercovici, Ana
Nechuta, Terry
Smith, Elizabeth M.
McElroy, William
Tan, Zheng
Tulshian, Deen
McKittrick, Brian
Greenlee, William J.
Hruza, Alan
Xiao, Li
Rindgen, Diane
Mullins, Deborra
Guzzi, Mario
Zhang, Xiaoping
Bleickardt, Carina
Hodgson, Robert
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1019 - 1022

← 1 2 3 4 5 →